Literature DB >> 18480047

Structural basis for the interaction of isoDGR with the RGD-binding site of alphavbeta3 integrin.

Andrea Spitaleri1, Silvia Mari, Flavio Curnis, Catia Traversari, Renato Longhi, Claudio Bordignon, Angelo Corti, Gian-Paolo Rizzardi, Giovanna Musco.   

Abstract

Asparagine deamidation at the NGR sequence in the 5th type I repeat of fibronectin (FN-I5) generates isoDGR, an alphavbeta3 integrin-binding motif regulating endothelial cell adhesion and proliferation. By NMR and molecular dynamics studies, we analyzed the structure of CisoDGRC (isoDGR-2C), a cyclic beta-peptide mimicking the FN-I5 site, and compared it with NGR, RGD, or DGR-containing cyclopeptides. Docking experiments show that isoDGR, exploiting an inverted orientation as compared with RGD, favorably interacts with the RGD-binding site of alphavbeta3, both recapitulating canonical RGD-alphavbeta3 contacts and establishing additional polar interactions. Conversely, NGR and DGR motifs lack the fundamental pharmacophoric requirements for high receptor affinity. Therefore, unlike NGR and DGR, isoDGR is a new natural recognition motif of the RGD-binding pocket of alphavbeta3. These findings contribute to explain the different functional properties of FN-I5 before and after deamidation, and provide support for the hypothesis that NGR --> isoDGR transition can work as a molecular timer for activating latent integrin-binding sites in proteins, thus regulating protein function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480047     DOI: 10.1074/jbc.M710273200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo.

Authors:  Gopal Pathuri; Andria F Hedrick; Bryan C Disch; John T Doan; Michael A Ihnat; Vibhudutta Awasthi; Hariprasad Gali
Journal:  Bioconjug Chem       Date:  2011-12-20       Impact factor: 4.774

2.  Directing integrin-linked endocytosis of recombinant AAV enhances productive FAK-dependent transduction.

Authors:  Paul M Kaminsky; Nicholas W Keiser; Ziying Yan; Diana C M Lei-Butters; John F Engelhardt
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

3.  Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.

Authors:  Mingli Xiang; Yuchun Lin; Gu He; Lijuan Chen; Mingli Yang; Shengyong Yang; Yirong Mo
Journal:  J Mol Model       Date:  2012-06-27       Impact factor: 1.810

4.  Structure and activity of CPNGRC: a modified CD13/APN peptidic homing motif.

Authors:  Leigh A Plesniak; Bridget Salzameda; Holly Hinderberger; Elizabeth Regan; James Kahn; Stephen A Mills; Peter Teriete; Yong Yao; Patricia Jennings; Francesca Marassi; Joseph A Adams
Journal:  Chem Biol Drug Des       Date:  2010-03-30       Impact factor: 2.817

5.  Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations.

Authors:  Jihong Li; Yoshiyuki Fukase; Yi Shang; Wei Zou; José M Muñoz-Félix; Lorena Buitrago; Johannes van Agthoven; Yixiao Zhang; Ryoma Hara; Yuta Tanaka; Rei Okamoto; Takeshi Yasui; Takashi Nakahata; Toshihiro Imaeda; Kazuyoshi Aso; Yuchen Zhou; Charles Locuson; Dragana Nesic; Mark Duggan; Junichi Takagi; Roger D Vaughan; Thomas Walz; Kairbaan Hodivala-Dilke; Steven L Teitelbaum; M Amin Arnaout; Marta Filizola; Michael A Foley; Barry S Coller
Journal:  ACS Pharmacol Transl Sci       Date:  2019-08-02

6.  De novo design of a tumor-penetrating peptide.

Authors:  Luca Alberici; Lise Roth; Kazuki N Sugahara; Lilach Agemy; Venkata R Kotamraju; Tambet Teesalu; Claudio Bordignon; Catia Traversari; Gian-Paolo Rizzardi; Erkki Ruoslahti
Journal:  Cancer Res       Date:  2012-11-14       Impact factor: 12.701

7.  iso-DGR sequences do not mediate binding of fibronectin N-terminal modules to adherent fibronectin-null fibroblasts.

Authors:  Jielin Xu; Lisa M Maurer; Brian R Hoffmann; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

Review 8.  The neovasculature homing motif NGR: more than meets the eye.

Authors:  Angelo Corti; Flavio Curnis; Wadih Arap; Renata Pasqualini
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

9.  Inhibition of tumor angiogenesis and tumor growth by the DSL domain of human Delta-like 1 targeted to vascular endothelial cells.

Authors:  Xing-Cheng Zhao; Guo-Rui Dou; Li Wang; Liang Liang; Deng-Mei Tian; Xiu-Li Cao; Hong-Yan Qin; Chun-Mei Wang; Ping Zhang; Hua Han
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

10.  Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching.

Authors:  Flavio Curnis; Angela Cattaneo; Renato Longhi; Angelina Sacchi; Anna Maria Gasparri; Fabio Pastorino; Paola Di Matteo; Catia Traversari; Angela Bachi; Mirco Ponzoni; Gian-Paolo Rizzardi; Angelo Corti
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.